Literature DB >> 28431317

Ambient PM2.5 exposure and premature mortality burden in the holy city Varanasi, India.

Vaishali Jain1, Sagnik Dey2, Sourangsu Chowdhury3.   

Abstract

More than 3 million population residing in the holy city Varanasi and sub-urban areas is exposed to very high level of fine particulate matter (PM2.5) from various sources. Continuous monitoring by Central Pollution Control Board started only in 2015; therefore what was the pollution level in the past and how it has changed over the years are not known. We use MODIS aerosol products to infer PM2.5 and examine 15-year climatology. Data shows a rapid (1.5-3% per year) increase in PM2.5 in the last 15 years and high (87% days in a year) persistence of PM2.5 above the national air quality standard. It translates to a burden of 5700 (2800-7500) annual premature deaths (0.16% of the population), of which 29%, 18%, 33%, 19% and remaining 1% are attributed to ischemic heart disease, stroke, chronic obstructive pulmonary disease, acute lower respiratory infection and lung cancer respectively. If the region achieves the Indian (WHO) air quality standard, 1900 (3800) premature deaths can be avoided every year.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28431317     DOI: 10.1016/j.envpol.2017.04.028

Source DB:  PubMed          Journal:  Environ Pollut        ISSN: 0269-7491            Impact factor:   8.071


  8 in total

1.  Spatiotemporal Assessment of PM2.5-Related Economic Losses from Health Impacts during 2014⁻2016 in China.

Authors:  Yang Yang; Liwen Luo; Chao Song; Hao Yin; Jintao Yang
Journal:  Int J Environ Res Public Health       Date:  2018-06-16       Impact factor: 3.390

2.  Effect of ambient air pollution on premature SGA in Changzhou city, 2013-2016: a retrospective study.

Authors:  Shushu Li; Huaiyan Wang; Haiting Hu; Zeying Wu; Kejin Chen; Zhilei Mao
Journal:  BMC Public Health       Date:  2019-06-07       Impact factor: 3.295

3.  Applying Integrated Exposure-Response Functions to PM2.5 Pollution in India.

Authors:  Vijay S Limaye; Wolfgang Schöpp; Markus Amann
Journal:  Int J Environ Res Public Health       Date:  2018-12-26       Impact factor: 3.390

4.  Association of Long-Term Exposure to Fine Particulate Matter and Cardio-Metabolic Diseases in Low- and Middle-Income Countries: A Systematic Review.

Authors:  Suganthi Jaganathan; Lindsay M Jaacks; Melina Magsumbol; Gagandeep K Walia; Nancy L Sieber; Roopa Shivasankar; Preet K Dhillon; Safraj Shahul Hameed; Joel Schwartz; Dorairaj Prabhakaran
Journal:  Int J Environ Res Public Health       Date:  2019-07-16       Impact factor: 3.390

5.  Leveraging Existing Cohorts to Study Health Effects of Air Pollution on Cardiometabolic Disorders: India Global Environmental and Occupational Health Hub.

Authors:  Gagandeep K Walia; Siddhartha Mandal; Suganthi Jaganathan; Lindsay M Jaacks; Nancy L Sieber; Preet K Dhillon; Bhargav Krishna; Melina S Magsumbol; Kishore K Madhipatla; Dimple Kondal; Richard A Cash; K Srinath Reddy; Joel Schwartz; D Prabhakaran
Journal:  Environ Health Insights       Date:  2020-04-20

6.  Particulate matter (PM10) enhances RNA virus infection through modulation of innate immune responses.

Authors:  Richa Mishra; Pandikannan Krishnamoorthy; S Gangamma; Ashwin Ashok Raut; Himanshu Kumar
Journal:  Environ Pollut       Date:  2020-07-13       Impact factor: 8.071

7.  Effect of exposure to PM10 on child health: evidence based on a large-scale survey from 184 cities in India.

Authors:  Bidhubhusan Mahapatra; Monika Walia; Wiliam Robert Avis; Niranjan Saggurti
Journal:  BMJ Glob Health       Date:  2020-08

8.  Development of Ahmedabad's Air Information and Response (AIR) Plan to Protect Public Health.

Authors:  Vijay S Limaye; Kim Knowlton; Sayantan Sarkar; Partha Sarthi Ganguly; Shyam Pingle; Priya Dutta; Sathish L M; Abhiyant Tiwari; Bhavin Solanki; Chirag Shah; Gopal Raval; Khyati Kakkad; Gufran Beig; Neha Parkhi; Anjali Jaiswal; Dileep Mavalankar
Journal:  Int J Environ Res Public Health       Date:  2018-07-10       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.